Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler
- PMID: 29592916
- DOI: 10.1136/annrheumdis-2018-213399
Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler
Keywords: rheumatoid arthritis; systemic lupus erythematosus; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE.Ann Rheum Dis. 2018 Jun;77(6):911-913. doi: 10.1136/annrheumdis-2017-212599. Epub 2018 Feb 9. Ann Rheum Dis. 2018. PMID: 29440000
-
Lack of standardisation of ANA and implications for drug development and precision medicine.Ann Rheum Dis. 2019 May;78(5):e33. doi: 10.1136/annrheumdis-2018-213374. Epub 2018 Mar 24. Ann Rheum Dis. 2019. PMID: 29574414 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
